iShares U.S. Healthcare ETF (IYH) Buys $17.4 Million More Eli Lilly on Oct. 8

gurufocus.com · 2026-10-12

ETF activity was one-sided on Thursday, with iShares U.S. Healthcare ETF (IYH) reporting 98 positions increased and none decreased. The fund, with $4.18 billion

TickrTrends take: The iShares U.S. Healthcare ETF increased its position in Eli Lilly, a direct competitor to Merck in the Healthcare sector, suggesting institutional confidence in that company's value proposition. Given that TickrTrends currently rates Merck as Overvalued, investors focusing on valuation metrics should monitor whether similar purchasing activity occurs in Merck positions or whether capital continues to flow toward peers that may offer better value. This competitive capital allocation could serve as a contrarian signal for those assessing Merck's relative attractiveness within the Healthcare space.

Read the full story at gurufocus.com →